PRT3789 is a First-in-Human SMARCA2-Selective Degrader that Induces Synthetic Lethality in SMARCA4-Mutated Cancers
1. 系统已在2025-11-18 18:32:36对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1158/0008-5472.can-25-1141
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Michael Hulse; Min Wang; Chaoyi Xu; Jack Carter; Anjana Agarwal; Liang Lu; Philip Pitis; Neha Bhagwat; Joseph Rager; Justin Kurian; Corey Basch; Monisha Sivakumar; Jessica Burtell; Arpita Mondal; Alexander Grego; Andrew Moore; Carly Bachner; Komali Vykuntam; Anthony Reichelderfer; Jimin Park; Joy Cote; Miles Cowart; Olusola Peace Osinubi; Ludovic Bigot; Alice Da Silva; Catline Nobre; Melissandre Meteau; Miguel Soares; Hsin-Yao Tang; Klare Bersch; Chaofeng Dai; Ganfeng Cao; Bo Shen; Tom Emm; Stefan Ruepp; Jennifer Xavier; Chris Tankersley; Diane Heiser; Sang Hyun Lee; Sandy Geeganage; Bruce Ruggeri; Hong Lin; William Novotny; Jane Huang; Kris Vaddi; Andrew Combs; Peggy Scherle; Koichi Ito
全文下载地址: https://aacrjournals.org/cancerres/article-pdf/doi/10.1158/0008-5472.CAN-25-1141/3655970/can-25-1141.pdf
